Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II double cord blood transplantation after reduced-intensity conditioning
NL-OMON26715Phase 2Active, not recruiting
- Sponsor
- HOVON
- Start
- Nov 2008
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial in Acute Leukaemia and hematopoietic malignancies, sponsored by HOVON. Primary endpoint: Cumulative incidence of graft failure. Started Nov 2008; status: active, not recruiting.
02
Conditions
Acute Leukaemiahematopoietic malignancies
Beyond the preview
Go deeper on NL-OMON26715.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON26715.